These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 33387124

  • 1. Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
    Kuo MH, Tseng CW, Lu MC, Tung CH, Tseng KC, Huang KY, Lee CH, Lai NS.
    Dig Dis Sci; 2021 Nov; 66(11):4026-4034. PubMed ID: 33387124
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 3. Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib.
    Wang ST, Tseng CW, Hsu CW, Tung CH, Huang KY, Lu MC, Lai NS.
    Int J Rheum Dis; 2021 Nov; 24(11):1362-1369. PubMed ID: 34506078
    [Abstract] [Full Text] [Related]

  • 4. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
    Ahn SS, Jung SM, Song JJ, Park YB, Park JY, Lee SW.
    Yonsei Med J; 2018 May; 59(3):452-456. PubMed ID: 29611409
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
    Tamori A, Koike T, Goto H, Wakitani S, Tada M, Morikawa H, Enomoto M, Inaba M, Nakatani T, Hino M, Kawada N.
    J Gastroenterol; 2011 Apr; 46(4):556-64. PubMed ID: 21246383
    [Abstract] [Full Text] [Related]

  • 6. Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
    Chen LF, Mo YQ, Jing J, Ma JD, Zheng DH, Dai L.
    Int J Rheum Dis; 2017 Jul; 20(7):859-869. PubMed ID: 28160426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.
    Varisco V, Viganò M, Batticciotto A, Lampertico P, Marchesoni A, Gibertini P, Pellerito R, Rovera G, Caporali R, Todoerti M, Covelli M, Notarnicola A, Atzeni F, Sarzi-Puttini P.
    J Rheumatol; 2016 May; 43(5):869-74. PubMed ID: 26879359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
    Tan J, Zhou J, Zhao P, Wei J.
    Clin Rheumatol; 2012 Aug; 31(8):1169-75. PubMed ID: 22544263
    [Abstract] [Full Text] [Related]

  • 11. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.
    Talotta R, Atzeni F, Sarzi Puttini P.
    BMC Pharmacol Toxicol; 2016 Apr 21; 17():17. PubMed ID: 27098382
    [Abstract] [Full Text] [Related]

  • 12. The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis.
    Ko PH, Kuo MH, Kao IT, Wu CY, Tseng CW, Shao SC.
    Viruses; 2024 Jan 03; 16(1):. PubMed ID: 38257778
    [Abstract] [Full Text] [Related]

  • 13. Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Tien YC, Yen HH, Chiu YM.
    Clin Exp Rheumatol; 2017 Jan 03; 35(5):831-836. PubMed ID: 28375829
    [Abstract] [Full Text] [Related]

  • 14. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
    Laohapand C, Arromdee E, Tanwandee T.
    Hepatol Int; 2015 Apr 03; 9(2):202-8. PubMed ID: 25788188
    [Abstract] [Full Text] [Related]

  • 15. Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Watanabe T, Fukae J, Fukaya S, Sawamukai N, Isobe M, Matsuhashi M, Shimizu M, Akikawa K, Tanimura K, Atsumi T, Koike T.
    Int J Rheum Dis; 2019 Apr 03; 22(4):574-582. PubMed ID: 30338649
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH, Bae SC, Song GG.
    Int J Rheum Dis; 2013 Oct 03; 16(5):527-31. PubMed ID: 24164839
    [Abstract] [Full Text] [Related]

  • 17. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun 03; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 18. HBV reactivation in HBsAg-/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs.
    Kuo MH, Tseng CW, Ko PH, Wang ST, Lu MC, Tung CH, Tseng KC, Huang KY, Lee CH, Lai NS.
    Liver Int; 2024 Feb 03; 44(2):497-507. PubMed ID: 38010984
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
    Loggi E, Gitto S, Galli S, Minichiello M, Conti F, Grandini E, Scuteri A, Vitale G, Di Donato R, Cursaro C, Furlini G, Andreone P.
    J Clin Virol; 2017 Aug 03; 93():66-70. PubMed ID: 28654775
    [Abstract] [Full Text] [Related]

  • 20. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.
    Eur J Haematol; 2010 Sep 03; 85(3):243-50. PubMed ID: 20491883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.